Joint Formulary & PAD

Anakinra - Haemophagocytic Lymphohistiocytosis (HLH)

You are here : Home > Formulary Search > Anakinra - Haemophagocytic Lymphohistiocytosis (HLH)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
NHSE
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Anakinra
Indication :
Haemophagocytic Lymphohistiocytosis (HLH)
Group Name :
Keywords :
HLH
Brand Names Include :
Kineret
Important Information :

For Adults Only

Latest Additions Date From :
18 Jun 2025
Latest Additions Date To :
18 Jul 2025
Guidelines :
Supporting Documents :
0

Committee Recommendations (2)

16 Sep 25 - SASH DTG

Approved for adults only.

06 Jun 25 - RSFT DTC

Approved for adults only

Other Indications

Below are listed other indications that Anakinra is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Haemophagocytic Lymphohistiocytosis (HLH) .

  • No records returned.